Zielinski CC - Search Results

1

Prognostic factors in metastatic renal cell carcinoma: metastasectomy as independent prognostic variable.

Vogl UM, Zehetgruber H, Dominkus M, Hejna M, Zielinski CC, Haitel A, Schmidinger M. Vogl UM, et al. Among authors: zielinski cc. Br J Cancer. 2006 Sep 18;95(6):691-8. doi: 10.1038/sj.bjc.6603327. Epub 2006 Aug 29. Br J Cancer. 2006. PMID: 16940978 Free PMC article.

2

Impaired production of tumor necrosis factor in breast cancer.

Zielinski CC, Mueller C, Tyl E, Tichatschek E, Kubista E, Spona J. Zielinski CC, et al. Cancer. 1990 Nov 1;66(9):1944-8. doi: 10.1002/1097-0142(19901101)66:9<1944::aid-cncr2820660916>3.0.co;2-w. Cancer. 1990. PMID: 2224791

3

Diagnostic value of mucin-like carcinoma-associated antigen (MCA) in breast cancer.

Rasoul-Rockenschaub S, Zielinski CC, Kubista E, Vavra N, Pospischil E, Staffen A, Czerwenka K, Aiginger P, Spona J. Rasoul-Rockenschaub S, et al. Among authors: zielinski cc. Eur J Cancer Clin Oncol. 1989 Jul;25(7):1067-72. doi: 10.1016/0277-5379(89)90390-8. Eur J Cancer Clin Oncol. 1989. PMID: 2759162

4

Natural killer cell activity in long-term survivors of testicular cancer. Influence of cytostatic therapy and initial stage of disease.

Krainer M, Wolf H, Michl I, Wiltschke C, Budinsky A, Kaider A, Kratzik C, Eibl MM, Zielinski CC. Krainer M, et al. Among authors: zielinski cc. Cancer. 1995 Jan 15;75(2):539-44. doi: 10.1002/1097-0142(19950115)75:2<539::aid-cncr2820750217>3.0.co;2-4. Cancer. 1995. PMID: 7529130

5

Reduced mitogenic stimulation of peripheral blood mononuclear cells as a prognostic parameter for the course of breast cancer: a prospective longitudinal study.

Wiltschke C, Krainer M, Budinsky AC, Berger A, Müller C, Zeillinger R, Speiser P, Kubista E, Eibl M, Zielinski CC. Wiltschke C, et al. Among authors: zielinski cc. Br J Cancer. 1995 Jun;71(6):1292-6. doi: 10.1038/bjc.1995.250. Br J Cancer. 1995. PMID: 7779726 Free PMC article.

6

Sperm analysis and serum follicle-stimulating hormone levels before and after adjuvant single-agent carboplatin therapy for clinical stage I seminoma.

Reiter WJ, Kratzik C, Brodowicz T, Haitel A, Pokorny A, Zielinski CC, Marberger M. Reiter WJ, et al. Among authors: zielinski cc. Urology. 1998 Jul;52(1):117-9. doi: 10.1016/s0090-4295(98)00139-3. Urology. 1998. PMID: 9671881

7

Paclitaxel and carboplatin in patients with metastatic urothelial cancer: results of a phase II trial.

Zielinski CC, Schnack B, Grbovic M, Brodowicz T, Wiltschke C, Steger G, Pflüger H, Marberger M. Zielinski CC, et al. Br J Cancer. 1998 Aug;78(3):370-4. doi: 10.1038/bjc.1998.501. Br J Cancer. 1998. PMID: 9703285 Free PMC article. Clinical Trial.

8

Inhibition of metastases by anticoagulants.

Hejna M, Raderer M, Zielinski CC. Hejna M, et al. Among authors: zielinski cc. J Natl Cancer Inst. 1999 Jan 6;91(1):22-36. doi: 10.1093/jnci/91.1.22. J Natl Cancer Inst. 1999. PMID: 9890167 Review.

9

Paclitaxel and carboplatin in patients with metastatic transitional cell cancer of the urinary tract.

Pycha A, Grbovic M, Posch B, Schnack B, Haitel A, Heinz-Peer G, Zielinski CC, Marberger M. Pycha A, et al. Among authors: zielinski cc. Urology. 1999 Mar;53(3):510-5. doi: 10.1016/s0090-4295(98)00543-3. Urology. 1999. PMID: 10096376 Clinical Trial.

10

Inhibition of proliferation and induction of apoptosis in soft tissue sarcoma cells by interferon-alpha and retinoids.

Brodowicz T, Wiltschke C, Kandioler-Eckersberger D, Grunt TW, Rudas M, Schneider SM, Hejna M, Budinsky A, Zielinski CC. Brodowicz T, et al. Among authors: zielinski cc. Br J Cancer. 1999 Jul;80(9):1350-8. doi: 10.1038/sj.bjc.6690528. Br J Cancer. 1999. PMID: 10424735 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

492 results

Search Page